In a randomised crossover trial of 11 participants with REM-predominant OSA, three nights of acetazolamide vs placebo reduced AHI by 35.5% and hypoxic burden by 35.9% (p<0.001), but did not mitigate REM dips in ventilatory drive.
RCTn = 11
Messineo et al. Acetazolamide to prevent ventilatory drive withdrawal in REM sleep apnoea: a randomised controlled trial